Visiongain Publishes Wearable Medical Devices Market Report 2021-2031

18 February 2021
Pharma

Visiongain has published a new report on Wearable Medical Devices Market Report 2021-2031: Forecasts by Type (Diagnostic (ECG, Heart, Pulse, BP, Sleep), Therapeutic (Pain, Insulin)), Application (Fitness, RPM), Product (Smartwatch, Patch), Grade (Consumer, Clinical), Channel (Pharmacy, Online). PLUS Profiles of Leading Pharma Contract Manufacturing Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios.

Global Wearable Medical Devices market was valued at US$ xx billion in 2020 and is projected to reach at a market value of US$ xx billion by 2031.

The term wearable medical devices describes independent devices that are worn by a person and provides medical monitoring or support over a long-lasting period of time. Their unique characteristic is that they are worn either as an accessory or are fixed into clothing. Such devices normally incorporate non-invasive physiological sensors, data processing modules, medical feedback, and wireless data transmission capabilities. They are small, light, unobtrusive, and designed for operation by unskilled users.

COVID-19 Impact on Wearable Medical Devices Market
The pandemic COVID 19 is increasing day by day in majority regions. And the threat of life is still remains the same. Along with this fear of life is increasing in every individual. People are becoming more aware about their health. People are avoiding to go hospitals for other health treatments. This market product are easily available and use of this product are friendly in nature. They can be used at residents. So this market is growing in this period of COVID 19.

Market Drivers
The growth of industries such as home healthcare and remote patient monitoring devices is expected to positively influence the demand for wearable devices. In addition increasing consumer focus on fitness and efforts towards leading a healthy lifestyle are expected to positively fuel the product demand.

The complexity and rise in healthcare have increased over recent years. Also due to inactive lifestyle, the incidence and prevalence of lifestyles- associated disorders, such as diabetes and hypertension is projected to increase over the future period. Some of these diseases demand continuous monitoring of several physiological parameters for example blood sugar and blood pressure levels. This reasons are driving this market to growth.

Market Opportunities
The therapeutic device segment is expected to expand over the period because of increasing influx of these products. Moreover a strong pipeline of therapeutic devices such as intelligent asthmamanagement devices, wearable pain reliever devices, and insulin management devices is expected to assist market growth.

Competitive Landscape
Global Wearable Medical Devices market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships,acquisitions and others to increase their footprints in this market
Some of the companies mentioned-Medtronic plc. (Ireland), Koninklijke Philips N.V. (Netherlands), OMRON Corporation (Japan), Biotelemetry Inc.(US),Apple, Inc. (US), Dexcom Inc. (US), Abbott Laboratories (US),Masimo Corporation(US),GE Healthcare(US), Bio-Beat Technologies (Israel), iRhythm Technologies, Inc. (US),VitalConnect (US), Minttihealth (US),Preventive Solutions, Inc. (US),CONTEC Medical Systems Co. Ltd (China), Biotricity Inc.(US), Verily Life Sciences. (US), Cyrcadia Asia Limited (Hong Kong), ten3T healthcare (India),Fitbit, Inc. (US) ,Garmin Ltd (Switzerland),Xiaomi Technologies (China) and Huawei Corporation (China).

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Biopharmaceuticals Contract Manufacturing Market Report 2022-2032

Ageing population will be more susceptible to such diseases and is one of the key factors driving the growth of the global biological drugs market. In most of the developed world, the share of elderly population is almost touching a quarter of the population.

26 January 2022

Read

Visiongain Publishes Topical Drug Delivery Market Report 2022-2032

Some of the factors driving the market growth are the increasing prevalence of skin and eye diseases, high incidences of burn incidences and the growing prevalence of diabetes.

26 January 2022

Read

Visiongain Publishes Decentralized Clinical Trials Market Report 2022-2032

The growing adoption advanced e-clinical solutions, rising focus on clinical research, increasing investment in R&D, and adoption of decentralized clinical trials by biopharmaceutical companies are some of the major factors that drive the growth of the global decentralized clinical trials market.

24 January 2022

Read

Visiongain Publishes Nasal Drug Delivery Technology Market Report 2022-2032

The nasal drug delivery market will expand rapidly due to rising patient preference for nasal medication delivery due to ease of administration and efficacy, increased self-administration practises, and increased demand for home healthcare equipment.

18 January 2022

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever